×

Themes

Diagnosis & treatment

Dual drug Piperine-Paclitaxel nanoparticles inhibit migration and invasion in human breast cancer cells.
Dual drug Piperine-Paclitaxel nanoparticles inhibit migration and invasion in human breast cancer cells.
Dr Monika Verma
Tepotinib in patients with MET exon 14 (METex14) skipping NSCLC: Analysis of all patients from VISION Cohorts A and C
Tepotinib in patients with MET exon 14 (METex14) skipping NSCLC: Analysis of all patients from VISION Cohorts A and C
Dr Louise Young
Clinical response to tepotinib according to circulating tumor (ct)DNA biomarkers in patients with advanced NSCLC with high-level MET amplification (METamp) detected by liquid biopsy (LBx)
Clinical response to tepotinib according to circulating tumor (ct)DNA biomarkers in patients with advanced NSCLC with high-level MET amplification (METamp) detected by liquid biopsy (LBx)
Dr Louise Young
	USING EX VIVO BIOENGINEERED LUNGS TO MODEL PATHOLOGIES AND SCREENING THERAPEUTICS
USING EX VIVO BIOENGINEERED LUNGS TO MODEL PATHOLOGIES AND SCREENING THERAPEUTICS
Mr Mohammadali Ahmadipour
Surgical Outcomes of Lung Cancer Surgery in Tasmania
Surgical Outcomes of Lung Cancer Surgery in Tasmania
Dr Ayeshmanthe Rathnayake
Real-world outcomes for patients with pleural mesothelioma: a multisite retrospective cohort study.
Real-world outcomes for patients with pleural mesothelioma: a multisite retrospective cohort study.
Dr Kar Ven Cavan Chow
Concurrent right-sided bronchial-pulmonary artery fistula and left-sided basaloid squamous cell carcinoma in a patient with recurrent haemoptysis
Concurrent right-sided bronchial-pulmonary artery fistula and left-sided basaloid squamous cell carcinoma in a patient with recurrent haemoptysis
Dr Natalie Nguyen
Extracellular Matrix Profiles Determine Risk and Prognosis of the Squamous Cell Carcinoma Subtype of Non-Small Cell Lung Carcinoma
Extracellular Matrix Profiles Determine Risk and Prognosis of the Squamous Cell Carcinoma Subtype of Non-Small Cell Lung Carcinoma
Dr Amelia Parker
Receipt of Guideline-Concordant Treatment in Lung Cancer by hospital insurance status in Victoria, Australia: A population based, propensity matched observational study.
Receipt of Guideline-Concordant Treatment in Lung Cancer by hospital insurance status in Victoria, Australia: A population based, propensity matched observational study.
Rob Stirling
Utilisation of thoracic radiotherapy for extensive stage small cell lung cancer in the era of chemoimmunotherapy: Experience from a multisite retrospective cohort study
Utilisation of thoracic radiotherapy for extensive stage small cell lung cancer in the era of chemoimmunotherapy: Experience from a multisite retrospective cohort study
Dr Cassie Turner
The incidence of rare and compound mutations of EGFR in non-small cell lung cancer and their potential clinical significance
The incidence of rare and compound mutations of EGFR in non-small cell lung cancer and their potential clinical significance
Dr Sharron Liang
Comparison of the 7th and 8th editions of AJCC TNM staging for non-small cell lung cancer: a population-based study in Queensland, Australia
Comparison of the 7th and 8th editions of AJCC TNM staging for non-small cell lung cancer: a population-based study in Queensland, Australia
Ms Shoni Philpot
12-month experience of a private university hospital multi-disciplinary team (MDT)
12-month experience of a private university hospital multi-disciplinary team (MDT)
Mrs Abby Fyfe
Delays to lung cancer surgery and pathological upstaging in a Western Australian tertiary centre
Delays to lung cancer surgery and pathological upstaging in a Western Australian tertiary centre
Dr Nicholas Bayfield
Sleep Quality Before and After Chemotherapy in Lung Cancer Patients - A Systematic Review and Meta-Analysis
Sleep Quality Before and After Chemotherapy in Lung Cancer Patients - A Systematic Review and Meta-Analysis
Dr RIshi Kumarahuru
First 110 cases of robotic-assisted thoracic surgery in Geelong, Australia. A cohort study.
First 110 cases of robotic-assisted thoracic surgery in Geelong, Australia. A cohort study.
Dr Manoras Mathew Chengalath
Stage III Non Small Cell Lung Cancer curative intent treatment: Does post code matter?
Stage III Non Small Cell Lung Cancer curative intent treatment: Does post code matter?
Ms Catherine Smith
Biomarkers for lung cancer screening - systematic review
Biomarkers for lung cancer screening - systematic review
Ms. Jazmin Guayco


No presentations found for today.